These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38695963)

  • 21. Cardiovascular risk factors in high-need psoriasis patients and its implications for biological therapies.
    Driessen RJ; Boezeman JB; Van De Kerkhof PC; De Jong EM
    J Dermatolog Treat; 2009; 20(1):42-7. PubMed ID: 18649164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular Risk in Psoriasis: Current State of the Art.
    Dattilo G; Borgia F; Guarneri C; Casale M; Bitto R; Morabito C; Signorelli S; Katsiki N; Cannavò SP
    Curr Vasc Pharmacol; 2019; 17(1):85-91. PubMed ID: 29149819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular biomarkers in patients with psoriasis.
    Gerdes S; Osadtschy S; Buhles N; Baurecht H; Mrowietz U
    Exp Dermatol; 2014 May; 23(5):322-5. PubMed ID: 24660963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does treatment of psoriasis reduce the risk of cardiovascular disease?
    Churton S; Brown L; Shin TM; Korman NJ
    Drugs; 2014 Feb; 74(2):169-82. PubMed ID: 24420963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Psoriasis and cardiovascular disease].
    Torres T; Sales R; Vasconcelos C; Selores M
    Acta Med Port; 2013; 26(5):601-7. PubMed ID: 24192101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions between vitamin D levels, cardiovascular risk factors, and atherothrombosis markers in patients with symptomatic peripheral artery disease.
    Da Porto A; Cavarape A; Catena C; Colussi G; Casarsa V; Sechi LA
    Vasc Med; 2021 Jun; 26(3):315-316. PubMed ID: 33448908
    [No Abstract]   [Full Text] [Related]  

  • 27. Psoriasis: the visible killer.
    Torres T; Bettencourt N
    Rev Port Cardiol; 2014 Feb; 33(2):95-9. PubMed ID: 24525359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of cardiovascular disease in patients with psoriasis.
    Egeberg A; Skov L
    Expert Opin Pharmacother; 2016 Aug; 17(11):1509-16. PubMed ID: 27192114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies.
    Prey S; Paul C; Bronsard V; Puzenat E; Gourraud PA; Aractingi S; Aubin F; Bagot M; Cribier B; Joly P; Jullien D; Le Maitre M; Richard-Lallemand MA; Ortonne JP
    J Eur Acad Dermatol Venereol; 2010 Apr; 24 Suppl 2():23-30. PubMed ID: 20443997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-Sensitivity Cardiac Troponin I and T for Cardiovascular Risk Stratification in Adults With Diabetes.
    Tang O; Matsushita K; Coresh J; Ndumele C; McEvoy JW; Sharrett AR; Hoogeveen R; Ballantyne CM; Selvin E
    Diabetes Care; 2020 Oct; 43(10):e144-e146. PubMed ID: 32788284
    [No Abstract]   [Full Text] [Related]  

  • 31. Cardiovascular Risk in Patients With Psoriasis: JACC Review Topic of the Week.
    Garshick MS; Ward NL; Krueger JG; Berger JS
    J Am Coll Cardiol; 2021 Apr; 77(13):1670-1680. PubMed ID: 33795041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and Consequences.
    Boehncke WH
    Front Immunol; 2018; 9():579. PubMed ID: 29675020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation and treatment of metabolic syndrome and cardiovascular disease in adult patients with psoriasis.
    Palmer V; Cornier MA; Waring A; Valdebran M
    Int J Dermatol; 2023 Dec; 62(12):1437-1446. PubMed ID: 37845786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging Cardiovascular Risk Factors and Specific Patient Populations at Increased Cardiovascular Risk.
    Katsiki N; Doumas M
    Curr Vasc Pharmacol; 2021; 19(3):241-242. PubMed ID: 33413053
    [No Abstract]   [Full Text] [Related]  

  • 35. Ustekinumab reduces serum protein levels associated with cardiovascular risk in psoriasis vulgaris.
    Koschitzky M; Navrazhina K; Garshick MS; Gonzalez J; Han J; Garcet S; Krueger JG
    Exp Dermatol; 2022 Sep; 31(9):1341-1351. PubMed ID: 35474520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dietary Inflammatory Index in relation to psoriasis risk, cardiovascular risk factors, and clinical outcomes: a case-control study in psoriasis patients.
    Kashani A; Moludi J; Lateef Fateh H; Tandorost A; Jafari-Vayghan H; Dey P
    Appl Physiol Nutr Metab; 2021 Dec; 46(12):1517-1524. PubMed ID: 34348057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Atherosclerosis and cardiovascular risk in patients with inflammatory bowel disease].
    Mironova OI; Isaikina MA; Khasieva SA
    Ter Arkh; 2021 Dec; 93(12):1533-1538. PubMed ID: 36286684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psoriasis: a skin disease associated with increased cardiovascular risk.
    González-Gay MA; González-Vela C; González-Juanatey C
    Actas Dermosifiliogr; 2012 Sep; 103(7):595-8. PubMed ID: 22465257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The assessment and management of psoriasis.
    Jackson K
    Nurs Times; 2013 Jul 17-23; 109(28):18-9. PubMed ID: 23971318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psoriasis and cardiovascular disorders.
    Frieder J; Ryan C
    G Ital Dermatol Venereol; 2016 Dec; 151(6):678-693. PubMed ID: 27627099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.